PARP inhibitor ABT-888 affects response of MDA-MB-231 cells to doxorubicin treatment, targeting Snail expression

To overcome cancer cells resistance to pharmacological therapy, the development of new therapeutic approaches becomes urgent. For this purpose, the use of poly(ADP-ribose) polymerase (PARP) inhibitors in combination with other cytotoxic agents could represent an efficacious strategy. Poly(ADP-ribosy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Mariano, Germano, Ricciardi, Maria Rosaria, Trisciuoglio, Daniela, Zampieri, Michele, Ciccarone, Fabio, Guastafierro, Tiziana, Calabrese, Roberta, Valentini, Elisabetta, Tafuri, Agostino, Del Bufalo, Donatella, Caiafa, Paola, Reale, Anna
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4558132/
https://ncbi.nlm.nih.gov/pubmed/25938539
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados